Aurinia Pharmaceuticals Inc. (AUPH) NASDAQ
15.36
+0.05(+0.33%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
15.36
+0.05(+0.33%)
Currency In USD
| Market Cap | 2.14B |
| Enterprise Value | 2.14B |
| P/E Ratio | 6.82 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 6.62 |
| Price/Book Ratio | 3.58 |
| Enterprise/Revenue | 6.71 |
| Enterprise/EBITDA | 12.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 1 |
| Operating Margin | 0.42 |
| Return On Assets | 0.41 |
| Return On Equity | 0.64 |
| Revenue | 283.06M |
| Revenue/Share | 2.25 |
| Gross Profit | 250.39M |
| EBITDA | 127.76M |
| Net Income | 287.2M |
| Diluted EPS | 2.07 |
| Total Cash | 378.78M |
| Total Cash/Share | 2.86 |
| Total Debt | 68.64M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 5.55 |
| Book Value Per Share | 4.29 |
| 52-Week Change | 92.96 |
| 52-Week High | 16.88 |
| 52-Week Low | 7.29 |
| Moving Average 50 Days | 15.52 |
| Moving Average 200 Days | 14.33 |
| Average Volume | 1.18M |
| Shares Outstanding | 128.6M |
| % Held by Institutions | 55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | October 23, 2013 |